Congenica is a global company founded on pioneering research from the Sanger Institute based at the Wellcome Genome Campus in Cambridge. We've translated this research into the gold standard clinical genomic analytics platform,  Sapientia®, providing integration of human DNA sequences with deep clinical phenotyping, enabling clinicians to provide actionable interpretation of genetic disease for patients. Our platform is used by clinicians and researchers across the world for clinical diagnosis, prognosis, and research.